New podcast episode explains the IDMP standards

Technology / 03 October 2022

National differences in identifying products and substances complicate pharmacovigilance. But the IDMP standards promise a harmonised, structured body of definitions. Learn how...


The Identification of Medicinal Products (IDMP) standards promise to harmonise how pharmaceutical products and substances are described around the world. But how will that benefit patients and who will make sure the standards are properly implemented?

Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund join Drug Safety Matters host Federica Santoro to discuss the advantages and challenges of this global standardisation effort.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

To find out even more about how IDMP will affect the future of pharmacovigilance – and what role UMC will play in that future – be sure to visit our information resources at:

You may also like


UMC breaks ground in automated coding for safety reports

A new study highlights the gains to be made in time, quality, and consistency from using UMC’s coding engine WHODrug Koda to automate drug coding in post-marketing surveillance.

Technology / 09 May 2022

UMC mobilises offline app for vaccine adverse event reporting

Now vaccination field workers can collect reports on adverse events following immunisation (AEFI) using a phone, tablet, or laptop even in the remotest of locations.

Technology / 20 September 2022

vigiGroup in action – new method identifies groups of related reports

See how UMC’s new clustering algorithm identifies groups of related reports in our new explainer animation.

Technology / 08 February 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more